Carmustine Chemotherapy: Uses, Dosage & Side Effects Explained

Summary of Key Points

Carmustine is a chemotherapy medication frequently prescribed to treat various cancers, including brain cancer, lymphomas, and multiple myeloma. It works by slowing or stopping the growth of cancer cells. This treatment is typically administered by a healthcare professional, either through an injection or as an implant. Like all medications, Carmustine may cause side effects, so it is crucial to discuss your treatment plan thoroughly with your doctor before starting therapy.

Names of the Medication

US Brand Name: BiCNU

Generic Name: Carmustine

The generic name refers to the chemical name of the active ingredient in a medication. In this case, Carmustine is the generic name and is often listed alongside the brand name for clarity.

Pharmacologic Category

Category: Alkylating Agent

Carmustine Dosage

Carmustine is used to treat several types of cancer, and the dosage depends on the specific condition being addressed. Always consult your doctor before making any changes to your prescribed dose. If needed, you can also schedule a telemedicine appointment with one of our providers to discuss your treatment plan in detail.

Carmustine for Brain Cancer (Glioblastoma, Astrocytoma)

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Carmustine for Hodgkin’s Lymphoma

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Carmustine for Non-Hodgkin’s Lymphoma

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Carmustine for Multiple Myeloma

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Carmustine for Melanoma

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Carmustine for Ovarian Cancer

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Carmustine for Lung Cancer

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Carmustine for Testicular Cancer

Dosage: 150-200 mg/m² intravenously every 6 weeks, divided into two doses over two days.

Dosage Forms and Strengths

Injection: 100 mg vial

Implant: 7.7 mg wafer

Administration Instructions

Carmustine is administered by a healthcare professional, either through an intravenous (IV) injection or as an implant placed during surgery. The IV form is infused slowly over 1-2 hours. The implant is specifically used during brain surgery to treat brain tumors. Always follow your doctor’s instructions carefully, and never attempt to administer this medication on your own.

Adverse Reactions and Side Effects

As with all medications, Carmustine can cause side effects. While some are common and manageable, others may be rare but more serious. If you experience any side effects, contact your healthcare provider promptly. You can also schedule a telemedicine appointment with one of our providers to address any concerns or questions.

Common Carmustine Side Effects

1. Nausea and Vomiting: Feeling nauseous or experiencing vomiting is a frequent reaction to treatment.
2. Fatigue: Many patients report feeling unusually tired or weak during therapy.
3. Loss of Appetite: A decreased desire to eat is another common side effect.

Less Common but Serious Side Effects

1. Bone Marrow Suppression: This condition can result in low blood cell counts, increasing the risk of infections, anemia, or bleeding.
2. Lung Damage: Prolonged use of Carmustine may lead to lung complications.
3. Liver or Kidney Damage: In rare cases, Carmustine can impair liver or kidney function.

Contraindications for Carmustine Chemotherapy

A contraindication refers to a specific condition or circumstance in which a treatment or medication, such as Carmustine chemotherapy, should not be used because it may pose significant risks to the patient. If you have any of the following conditions, Carmustine may not be a safe option for you.

Allergy to Carmustine: If you are allergic to Carmustine or any of its components, using this medication could lead to severe allergic reactions. Symptoms may include difficulty breathing, skin rash, or swelling. It is crucial to inform your healthcare provider about any known allergies before starting treatment.

Severely Impaired Lung Function: Carmustine has the potential to damage lung tissue, particularly when administered at higher doses. If you already have a significant lung condition, such as chronic obstructive pulmonary disease (COPD) or pulmonary fibrosis, this medication could exacerbate your symptoms and further compromise lung function.

Severe Bone Marrow Suppression: Carmustine suppresses the bone marrow’s ability to produce blood cells, which can result in dangerously low levels of red blood cells, white blood cells, and platelets. If you already have reduced blood cell counts due to a pre-existing condition or prior treatments, Carmustine may increase your risk of serious complications, such as infections, excessive bleeding, or severe anemia.

Pregnancy: Carmustine can cause harm to an unborn baby (see the section on “Carmustine in Pregnancy” below). If you are pregnant or planning to become pregnant, this medication is not recommended. Always discuss your options with your healthcare provider to ensure the safety of both you and your baby.

Drug-to-Drug Interactions with Carmustine

Carmustine chemotherapy can interact with other medications, potentially intensifying side effects or reducing the effectiveness of treatment. It is essential to inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, supplements, and herbal remedies. Some notable interactions include:

1. Phenytoin (Dilantin): This anti-seizure medication may decrease the effectiveness of Carmustine, while Carmustine can lower Phenytoin levels, potentially increasing the risk of seizures. Close monitoring is required if these medications are used together.
2. Warfarin (Coumadin): Combining Carmustine with blood thinners like Warfarin may elevate the risk of bleeding. Your healthcare provider may need to adjust your dosage or monitor your blood clotting levels more frequently.
3. Live Vaccines: Vaccines such as MMR (measles, mumps, rubella) or varicella (chickenpox) may be less effective when administered during Carmustine treatment. Additionally, because Carmustine weakens the immune system, live vaccines could increase the risk of developing the infection the vaccine is designed to prevent.
4. Other Chemotherapy Drugs: Medications like Cyclophosphamide (Cytoxan) or Doxorubicin (Adriamycin) may heighten the risk of bone marrow suppression when used in combination with Carmustine. Your healthcare provider will carefully weigh the benefits and risks of combining these treatments.

Carmustine in Pregnancy

Is it safe to take Carmustine during pregnancy?

No, Carmustine is not considered safe during pregnancy. It is classified as a Category D medication, meaning there is evidence of potential harm to an unborn baby. Carmustine can cause serious complications, including birth defects or miscarriage. If you are pregnant or planning to become pregnant, it is essential to discuss alternative treatment options with your healthcare provider. Individuals of childbearing age should use reliable birth control methods while undergoing Carmustine treatment and for a specified period after completing therapy. If you become pregnant while receiving Carmustine, contact your healthcare provider immediately to discuss next steps.

Carmustine While Breastfeeding

Is it safe to take Carmustine while breastfeeding?

No, Carmustine is not safe to use while breastfeeding. The medication can pass into breast milk and may harm a nursing infant. Breastfeeding should be avoided during Carmustine treatment and for a designated period afterward. If you are currently breastfeeding or planning to breastfeed, consult your healthcare provider to explore alternative feeding options for your baby, such as formula or donor milk, to ensure your child’s safety.

Estimated Cost of Carmustine Chemotherapy

The cost of Carmustine can vary significantly depending on the pharmacy and location. Without insurance, a 30-day supply of Carmustine typically costs between $1,000 and $2,500 when using a GoodRx coupon. Prices may fluctuate, so it’s important to check with your local pharmacy or consider using a discount service like GoodRx to find the most affordable option available.

Possible Alternatives to Carmustine Treatment

If Carmustine is not a suitable option for your treatment, other medications and therapies may be available based on your specific condition. It’s essential to consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to discuss alternative options in greater detail.

Brain Cancer

For brain cancer, alternatives may include chemotherapy agents such as Temozolomide (Temodar) or radiation therapy. Depending on the type and location of the tumor, surgery might also be an option.

Hodgkin’s Lymphoma

Treatment alternatives for Hodgkin’s lymphoma include chemotherapy regimens like ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) or radiation therapy.

Non-Hodgkin’s Lymphoma

Options for non-Hodgkin’s lymphoma may involve targeted therapies such as Rituximab (Rituxan), chemotherapy, radiation therapy, or stem cell transplantation.

Multiple Myeloma

For multiple myeloma, alternatives include medications like Bortezomib (Velcade) and Lenalidomide (Revlimid). Stem cell transplantation is another potential treatment option.

Melanoma

Immunotherapy drugs such as Pembrolizumab (Keytruda) or Nivolumab (Opdivo) are commonly used for melanoma. Surgery and radiation therapy may also be part of the treatment plan.

Ovarian Cancer

Alternatives for ovarian cancer include chemotherapy agents like Paclitaxel (Taxol) or Carboplatin. Surgery often plays a central role in the treatment process.

Lung Cancer

For lung cancer, targeted therapies such as Erlotinib (Tarceva) or immunotherapy drugs like Nivolumab (Opdivo) may be considered. Surgery and radiation therapy are additional options, depending on the stage of the cancer.

Testicular Cancer

Cisplatin-based chemotherapy regimens or surgery are common alternatives for treating testicular cancer.

Glioblastoma

Temozolomide (Temodar) is a frequently used alternative for glioblastoma, often in combination with radiation therapy.

Astrocytoma

Treatment options for astrocytoma may include surgery, radiation therapy, or chemotherapy agents such as Temozolomide (Temodar).

Recent Updates on Carmustine Research

Recent advancements in Carmustine research focus on improving its delivery to cancer cells while minimizing side effects. One innovative approach involves the use of biodegradable wafers that release Carmustine directly into the brain following surgery for tumors like glioblastoma. This localized delivery method reduces systemic side effects and may enhance outcomes for patients with brain cancer.

Additionally, clinical trials are investigating the combination of Carmustine with newer immunotherapy drugs to boost the immune system’s ability to fight cancer. Although these studies are still in their early stages, they hold promise for developing more effective and less toxic treatment options in the future.

As research continues to evolve, staying informed about new developments is vital. If you’re interested in exploring the latest treatment options or participating in a clinical trial, discuss these possibilities with your healthcare provider during your next telemedicine appointment.

James Kingsley

Learn More